{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:10:59Z","timestamp":1769587859154,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00210-023-02458-w","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T23:51:13Z","timestamp":1679874673000},"page":"2095-2103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Distribution of [11C]-JNJ-42491293 in the marmoset brain: a positron emission tomography study"],"prefix":"10.1007","volume":"396","author":[{"given":"Min Su","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adjia","family":"Hamadjida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"B\u00e9dard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G.","family":"Nuara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim C.","family":"Gourdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Aliaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hopewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Bdair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Lucas","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gassan","family":"Massarweh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Huot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"issue":"20","key":"2458_CR1","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1021\/jm300912k","volume":"55","author":"JI Andres","year":"2012","unstructured":"Andres JI, Alcazar J, Cid JM, De Angelis M, Iturrino L, Langlois X, Lavreysen H, Trabanco AA, Celen S, Bormans G (2012) Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging. J Med Chem 55(20):8685\u20138699. https:\/\/doi.org\/10.1021\/jm300912k","journal-title":"J Med Chem"},{"key":"2458_CR2","doi-asserted-by":"publisher","first-page":"105697","DOI":"10.1016\/j.nbd.2022.105697","volume":"168","author":"F Campanelli","year":"2022","unstructured":"Campanelli F, Natale G, Marino G, Ghiglieri V, Calabresi P (2022) Striatal glutamatergic hyperactivity in Parkinson\u2019s disease. Neurobiol Dis 168:105697. https:\/\/doi.org\/10.1016\/j.nbd.2022.105697","journal-title":"Neurobiol Dis"},{"issue":"20","key":"2458_CR3","doi-asserted-by":"publisher","first-page":"8770","DOI":"10.1021\/jm3010724","volume":"55","author":"JM Cid","year":"2012","unstructured":"Cid JM, Tresadern G, Vega JA, de Lucas AI, Matesanz E, Iturrino L, Linares ML, Garcia A, Andres JI, Macdonald GJ, Oehlrich D, Lavreysen H, Megens A, Ahnaou A, Drinkenburg W, Mackie C, Pype S, Gallacher D, Trabanco AA (2012) Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor. J Med Chem 55(20):8770\u20138789. https:\/\/doi.org\/10.1021\/jm3010724","journal-title":"J Med Chem"},{"key":"2458_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/7355_2014_48","volume-title":"Small molecule therapeutics for schizophrenia","author":"JM Cid","year":"2015","unstructured":"Cid JM, Trabanco AA, Lavreysen H (2015) Metabotropic glutamate receptor 2 activators. In: Celanire S, Poli S (eds) Small molecule therapeutics for schizophrenia, vol 13. Springer, Switzerland, pp 101\u2013142"},{"issue":"1","key":"2458_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1152\/physrev.00062.2017","volume":"99","author":"GA Dienel","year":"2019","unstructured":"Dienel GA (2019) Brain Glucose Metabolism: Integration of Energetics with Function. Physiol Rev 99(1):949\u20131045. https:\/\/doi.org\/10.1152\/physrev.00062.2017","journal-title":"Physiol Rev"},{"issue":"5","key":"2458_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1124\/molpharm.121.000460","volume":"101","author":"S Dogra","year":"2022","unstructured":"Dogra S, Conn PJ (2022) Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia. Mol Pharmacol 101(5):275\u2013285. https:\/\/doi.org\/10.1124\/molpharm.121.000460","journal-title":"Mol Pharmacol"},{"issue":"1","key":"2458_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00702-020-02287-8","volume":"128","author":"I Frouni","year":"2021","unstructured":"Frouni I, Kwan C, Nuara SG, Belliveau S, Kang W, Hamadjida A, Bedard D, Gourdon JC, Huot P (2021) Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset. J Neural Transm (vienna) 128(1):73\u201381. https:\/\/doi.org\/10.1007\/s00702-020-02287-8","journal-title":"J Neural Transm (vienna)"},{"issue":"1","key":"2458_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1124\/pr.119.019133","volume":"73","author":"KJ Gregory","year":"2021","unstructured":"Gregory KJ, Goudet C (2021) International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors. Pharmacol Rev 73(1):521\u2013569. https:\/\/doi.org\/10.1124\/pr.119.019133","journal-title":"Pharmacol Rev"},{"issue":"12","key":"2458_CR9","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1111\/ejn.14679","volume":"51","author":"A Hamadjida","year":"2020","unstructured":"Hamadjida A, Sid-Otmane L, Kwan C, Frouni I, Nafade V, Bedard D, Gagnon D, Wallman MJ, Rouillard C, Parent A, Parent M, Huot P (2020) The highly selective mGlu2 receptor positive allosteric modulator LY-487,379 alleviates l-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson\u2019s disease. Eur J Neurosci 51(12):2412\u20132422. https:\/\/doi.org\/10.1111\/ejn.14679","journal-title":"Eur J Neurosci"},{"issue":"4","key":"2458_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1124\/pharmrev.120.000131","volume":"73","author":"KB Hansen","year":"2021","unstructured":"Hansen KB, Wollmuth LP, Bowie D, Furukawa H, Menniti FS, Sobolevsky AI, Swanson GT, Swanger SA, Greger IH, Nakagawa T, McBain CJ, Jayaraman V, Low CM, Dell\u2019Acqua ML, Diamond JS, Camp CR, Perszyk RE, Yuan H, Traynelis SF (2021) Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels. Pharmacol Rev 73(4):298\u2013487. https:\/\/doi.org\/10.1124\/pharmrev.120.000131","journal-title":"Pharmacol Rev"},{"key":"2458_CR11","unstructured":"Hori Y, Autio JA, Ohno M, Kawabata Y, Urushibata Y, Murata K, Yamaguchi M, Kawasaki A, Takeda C, Yokoyama C, Glasser M, Hayashi T (2018) Translating the Human Connectome Project to Marmoset Imaging: 16-Channel Multi-Array Coil and HCP-Style MRI Protocols and Preprocessing. In: ISMRM, Paris"},{"issue":"7","key":"2458_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2015.01.014","volume":"78","author":"Z Justinova","year":"2015","unstructured":"Justinova Z, Panlilio LV, Secci ME, Redhi GH, Schindler CW, Cross AJ, Mrzljak L, Medd A, Shaham Y, Goldberg SR (2015) The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys. Biol Psychiatry 78(7):452\u2013462. https:\/\/doi.org\/10.1016\/j.biopsych.2015.01.014","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2458_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00213-004-2025-1","volume":"179","author":"M Kellner","year":"2005","unstructured":"Kellner M, Muhtz C, Stark K, Yassouridis A, Arlt J, Wiedemann K (2005) Effects of a metabotropic glutamate(2\/3) receptor agonist (LY544344\/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results. Psychopharmacology 179(1):310\u2013315. https:\/\/doi.org\/10.1007\/s00213-004-2025-1","journal-title":"Psychopharmacology"},{"issue":"1S","key":"2458_CR14","first-page":"161","volume":"37","author":"S Krause","year":"2017","unstructured":"Krause S, Li Z, Teceno T, Hagiwara H, Takaishi M, McCracken P (2017) Characterization of a novel mGluR2\/3 PET tracer [18F] ER-000604699 in marmoset [Abstract]. J Cereb Blood Flow Metab 37(1S):161\u2013162","journal-title":"J Cereb Blood Flow Metab"},{"key":"2458_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuroscience.2021.11.009","volume":"480","author":"C Kwan","year":"2022","unstructured":"Kwan C, Kang MS, Nuara SG, Gourdon JC, Bedard D, Tardif CL, Hopewell R, Ross K, Bdair H, Hamadjida A, Massarweh G, Soucy JP, Luo W, Del Cid PE, Shlaifer I, Durcan TM, Fon EA, Rosa-Neto P, Frey S, Huot P (2022) Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset. Neuroscience 480:143\u2013154. https:\/\/doi.org\/10.1016\/j.neuroscience.2021.11.009","journal-title":"Neuroscience"},{"issue":"4","key":"2458_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s11064-021-03510-y","volume":"47","author":"W Lai","year":"2022","unstructured":"Lai W, Du D, Chen L (2022) Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review. Neurochem Res 47(4):844\u2013859. https:\/\/doi.org\/10.1007\/s11064-021-03510-y","journal-title":"Neurochem Res"},{"issue":"1","key":"2458_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2967\/jnumed.116.176628","volume":"58","author":"G Leurquin-Sterk","year":"2017","unstructured":"Leurquin-Sterk G, Celen S, Van Laere K, Koole M, Bormans G, Langlois X, Van Hecken A, Te Riele P, Alcazar J, Verbruggen A, de Hoon J, Andres JI, Schmidt ME (2017) What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2. J Nucl Med 58(1):110\u2013116. https:\/\/doi.org\/10.2967\/jnumed.116.176628","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"2458_CR18","first-page":"548","volume":"58","author":"Z Li","year":"2017","unstructured":"Li Z, Hagiwara H, Takaishi M, Teceno T, Krause S, Sasaki T, McCracken P, Koyama A, Terauchi T (2017) Discovery of a new class of mGluR2 selective group II mGluR NAM PET tracer [Abstract]. J Nucl Med 58(Suppl 1):548","journal-title":"J Nucl Med"},{"issue":"1\u20133","key":"2458_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.schres.2016.02.001","volume":"172","author":"RE Litman","year":"2016","unstructured":"Litman RE, Smith MA, Doherty JJ, Cross A, Raines S, Gertsik L, Zukin SR (2016) AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study. Schizophr Res 172(1\u20133):152\u2013157. https:\/\/doi.org\/10.1016\/j.schres.2016.02.001","journal-title":"Schizophr Res"},{"issue":"Suppl 2","key":"2458_CR20","first-page":"213","volume":"57","author":"T Lohith","year":"2016","unstructured":"Lohith T, McQuade P, Salinas C, Anderson M, Reynders T, Bautmans A, Bormans G, Serdon K, Van Laere K, Hostetler E (2016) First-in-human PET imaging of mGluR2 receptors [Abstract]. J Nucl Med 57(Suppl 2):213","journal-title":"J Nucl Med"},{"key":"2458_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuropharm.2016.08.032","volume":"111","author":"L Lundstrom","year":"2016","unstructured":"Lundstrom L, Bissantz C, Beck J, Dellenbach M, Woltering TJ, Wichmann J, Gatti S (2016) Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2. Neuropharmacology 111:253\u2013265. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.032","journal-title":"Neuropharmacology"},{"issue":"11","key":"2458_CR22","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/cne.24023","volume":"524","author":"P Majka","year":"2016","unstructured":"Majka P, Chaplin TA, Yu HH, Tolpygo A, Mitra PP, Wojcik DK, Rosa MG (2016) Towards a comprehensive atlas of cortical connections in a primate brain: Mapping tracer injection studies of the common marmoset into a reference digital template. J Comp Neurol 524(11):2161\u20132181. https:\/\/doi.org\/10.1002\/cne.24023","journal-title":"J Comp Neurol"},{"issue":"8","key":"2458_CR23","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1111\/bcp.13252","volume":"83","author":"J McColm","year":"2017","unstructured":"McColm J, Brittain C, Suriyapperuma S, Swanson S, Tauscher-Wisniewski S, Foster J, Soon D, Jackson K (2017) Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects. Br J Clin Pharmacol 83(8):1654\u20131667. https:\/\/doi.org\/10.1111\/bcp.13252","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2458_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/BF02253527","volume":"111","author":"WJ McEntee","year":"1993","unstructured":"McEntee WJ, Crook TH (1993) Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology 111(4):391\u2013401. https:\/\/doi.org\/10.1007\/BF02253527","journal-title":"Psychopharmacology"},{"issue":"Suppl 2","key":"2458_CR25","first-page":"290","volume":"57","author":"P McQuade","year":"2016","unstructured":"McQuade P, Joshi A, Miller P, Zeng Z, Purcell M, Gantert L, Holahan M, Meissner R, Uslaner J, Hostetler E (2016) Discovery and Preclinical Evaluation of an mGluR2-NAM PET Radioligand [Abstract]. J Nucl Med 57(Suppl 2):290","journal-title":"J Nucl Med"},{"issue":"5","key":"2458_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1124\/mol.117.110114","volume":"93","author":"DE O'Brien","year":"2018","unstructured":"O\u2019Brien DE, Shaw DM, Cho HP, Cross AJ, Wesolowski SS, Felts AS, Bergare J, Elmore CS, Lindsley CW, Niswender CM, Conn PJ (2018) Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators. Mol Pharmacol 93(5):526\u2013540. https:\/\/doi.org\/10.1124\/mol.117.110114","journal-title":"Mol Pharmacol"},{"issue":"9","key":"2458_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/nm1632","volume":"13","author":"ST Patil","year":"2007","unstructured":"Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD (2007) Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 13(9):1102\u20131107. https:\/\/doi.org\/10.1038\/nm1632","journal-title":"Nat Med"},{"issue":"7","key":"2458_CR28","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.str.2017.05.021","volume":"25","author":"L Perez-Benito","year":"2017","unstructured":"Perez-Benito L, Doornbos MLJ, Cordomi A, Peeters L, Lavreysen H, Pardo L, Tresadern G (2017) Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor. Structure 25(7):1153-1162 e1154. https:\/\/doi.org\/10.1016\/j.str.2017.05.021","journal-title":"Structure"},{"issue":"4","key":"2458_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/0269881115573403","volume":"29","author":"H Salih","year":"2015","unstructured":"Salih H, Anghelescu I, Kezic I, Sinha V, Hoeben E, Van Nueten L, De Smedt H, De Boer P (2015) Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies. J Psychopharmacol 29(4):414\u2013425. https:\/\/doi.org\/10.1177\/0269881115573403","journal-title":"J Psychopharmacol"},{"key":"2458_CR30","doi-asserted-by":"publisher","first-page":"172957","DOI":"10.1016\/j.ejphar.2020.172957","volume":"873","author":"L Sid-Otmane","year":"2020","unstructured":"Sid-Otmane L, Hamadjida A, Nuara SG, Bedard D, Gaudette F, Gourdon JC, Michaud V, Beaudry F, Panisset M, Huot P (2020) Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset. Eur J Pharmacol 873:172957. https:\/\/doi.org\/10.1016\/j.ejphar.2020.172957","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2458_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11307-021-01586-0","volume":"23","author":"G Yuan","year":"2021","unstructured":"Yuan G, Guehl NJ, Zheng B, Qu X, Moon SH, Dhaynaut M, Shoup TM, Afshar S, Kang HJ, Zhang Z, El Fakhri G, Normandin MD, Brownell AL (2021) Synthesis and Characterization of [(18)F]JNJ-46356479 as the First (18)F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2. Mol Imaging Biol 23(4):527\u2013536. https:\/\/doi.org\/10.1007\/s11307-021-01586-0","journal-title":"Mol Imaging Biol"},{"issue":"14","key":"2458_CR32","doi-asserted-by":"publisher","first-page":"9939","DOI":"10.1021\/acs.jmedchem.2c00593","volume":"65","author":"G Yuan","year":"2022","unstructured":"Yuan G, Dhaynaut M, Guehl NJ, Afshar S, Huynh D, Moon SH, Iyengar SM, Jain MK, Pickett JE, Kang HJ, Ondrechen MJ, El Fakhri G, Normandin MD, Brownell AL (2022a) Design, Synthesis, and Characterization of [(18)F]mG2P026 as a High-Contrast PET Imaging Ligand for Metabotropic Glutamate Receptor 2. J Med Chem 65(14):9939\u20139954. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00593","journal-title":"J Med Chem"},{"issue":"3","key":"2458_CR33","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1021\/acs.jmedchem.1c02004","volume":"65","author":"G Yuan","year":"2022","unstructured":"Yuan G, Dhaynaut M, Lan Y, Guehl NJ, Huynh D, Iyengar SM, Afshar S, Jain MK, Pickett JE, Kang HJ, Wang H, Moon SH, Ondrechen MJ, Wang C, Shoup TM, El Fakhri G, Normandin MD, Brownell AL (2022b) Synthesis and Characterization of 5-(2-Fluoro-4-[(11)C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2. J Med Chem 65(3):2593\u20132609. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c02004","journal-title":"J Med Chem"},{"issue":"2","key":"2458_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0271678X221130387","volume":"43","author":"G Yuan","year":"2023","unstructured":"Yuan G, Dhaynaut M, Guehl NJ, Neelamegam R, Moon SH, Qu X, Poutiainen P, Afshar S, Fakhri GE, Normandin MD, Brownell AL (2023) PET imaging studies to investigate functional expression of mGluR2 using [(11)C]mG2P001. J Cereb Blood Flow Metab 43(2):296\u2013308. https:\/\/doi.org\/10.1177\/0271678X221130387","journal-title":"J Cereb Blood Flow Metab"},{"issue":"24","key":"2458_CR35","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.7150\/thno.42587","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang Y, Chen Z, Shao T, Van R, Kumata K, Deng X, Fu H, Yamasaki T, Rong J, Hu K, Hatori A, Xie L, Yu Q, Ye W, Xu H, Sheffler DJ, Cosford NDP, Shao Y, Tang P, Wang L, Zhang MR, Liang SH (2020) Synthesis and preliminary studies of (11)C-labeled tetrahydro-1,7-naphthyridine-2-carboxamides for PET imaging of metabotropic glutamate receptor 2. Theranostics 10(24):11178\u201311196. https:\/\/doi.org\/10.7150\/thno.42587","journal-title":"Theranostics"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02458-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T06:05:55Z","timestamp":1691474755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02458-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2458"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02458-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Experiments were approved by McGill University and the Montreal Neurological Institute-Hospital (The Neuro) Animal Care Committees, which are in accordance with the regulations defined by the Canadian Council on Animal Care (Animal Use Protocol 2017\u20137922).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"1) Research project: A. Conception, B. Organisation, C. Execution;2) Manuscript: A. Writing of the first draft, B. Review and Critique.Kang: 1C,2A,2B; Hamadjida: 1B,1C,2A,2B; B\u00e9dard: 1C,2B; Nuara: 1C,2B; Gourdon: 1A, 2B; Frey: 1B,1C,2B; AA: 1C,2A; Ross: 1C,2B; Hopewell: 1C,2B; Bdair: 1C; Mathieu: 1C.2B; Tardif: 1C,2B; Soucy: 1C,2B; Massarweh: 1C,2B; Rosa-Neto:1C,2B; Huot: 1A,1B,2A,2B.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 roles"}},{"value":"PH has received payments from ConSynance Therapeutics, Neurodiem, AbbVie, Throughline Strategies, Sanford Burnham Prebys, adMare BioInnovations and Sunovion.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}}]}}